Humacyte, Inc. (HUMA) has 3 SEC Form 4 insider filings on record in the last 90 days. That includes 3 insider purchases totalling $30K. Most recent filing: Sept. 15, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Sept. 15, 2026 filed Sept. 14, 2026 | Jones Keith Anthony Director | +$5,620 | 10,000 | +25% | No | |
|
|
||||||
| Aug. 21, 2026 filed Aug. 20, 2026 | Jones Keith Anthony Director | +$6,930 | 10,000 | +33% | No | |
|
|
||||||
| Aug. 19, 2026 filed Aug. 17, 2026 | Jones Keith Anthony Director | +$17,820 | 30,000 | New | No | |
|
|
||||||
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free